LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.66 | 84.90 | 437 | 285 | 1.5294 | 1.5492 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 2.66 | 84.90 | 639 | 285 | 2.2363 | 2.1671 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.36 | 84.90 | 586 | 322 | 1.8167 | 1.7268 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 4.36 | 84.90 | 751 | 322 | 2.3282 | 2.1017 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.06 | 84.90 | 691 | 365 | 1.8908 | 1.7064 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 6.06 | 84.90 | 885 | 365 | 2.4217 | 2.0439 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.77 | 84.90 | 768 | 411 | 1.8675 | 1.6315 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 7.77 | 84.90 | 990 | 411 | 2.4074 | 1.9421 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.47 | 84.90 | 827 | 447 | 1.8483 | 1.5840 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.47 | 84.90 | 1049 | 447 | 2.3445 | 1.8533 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.18 | 84.90 | 893 | 492 | 1.8137 | 1.5293 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 11.18 | 84.90 | 1124 | 492 | 2.2829 | 1.7694 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | E06 |